Isles' Matthew Schaefer wins Calder Trophy as NHL's top rookie

New York Islanders defenseman Matthew Schaefer was named the 2025-26 Calder Memorial Trophy winner on Wednesday.

Field Level Media

The award is presented to the player who was the most proficient in his first year in the league.

Schaefer, at 18 years, 223 days on the final day of the regular season, is the youngest winner of the award in NHL history. He is one day younger than Colorado Avalanche center Nathan MacKinnon in 2013-14.

Schaefer received all 198 first-place votes and finished with 1,980 points. He is the first unanimous recipient of the award since Teemu Selanne of the Winnipeg Jets received first-place votes on all 50 ballots cast in 1992-93.

Montreal Canadiens forward Ivan Demidov pocketed 120 second-place votes and finished with 1,158 points, followed by Anaheim Ducks forward Beckett Sennecke (41, 958).

Schaefer, the top overall pick of the 2025 NHL Draft, learned that he won the award when his father, Todd, and brother, Johnathon, showed up on the set of ABC's "GMA3" in New York. The latter two traveled from the Toronto suburbs to share in Matthew's honor.

Advertisement

"We've got a lot of good family," said Matthew Schaefer, 18, "My mom's helped me and my family so much with everything; obviously we've had some tough losses, but it hasn't stopped us as a family. We've gotten a lot closer. For you guys to be here ... it means a lot. This year was super important to me."

Schaefer's mother, Jennifer, died in 2024 from breast cancer.

Schaefer led all first-year players in ice time (24:41) this season and shared the NHL lead in goals (23) while playing in all 82 games.

Demidov, the No. 5 overall pick in the 2024 NHL Draft, led all 2025-26 rookies in points (62) and assists (43).

Sennecke was tied with Schaefer for the rookie lead in goals and finished two points behind Demidov with 60 points.

--Field Level Media

Isles' Matthew Schaefer wins Calder Trophy as NHL's top rookie

New York Islanders defenseman Matthew Schaefer was named the 2025-26 Calder Memorial Trophy winner on Wednesday. The award is pre...
Why are so many U.S. CEOs in China with Trump, and what do they want?

Tech CEOs in China with Trump make cases for more economic partnerships 02:16

CBS News

Chinese President Xi Jinping told U.S. CEOstraveling with President Trumpto China that it will open further to American business, a key goal for corporate leaders eager to expand their presence in the world's second-largest economy.

Xi spoke with the delegation of chief executives, which includes Apple CEO Tim Cook, Tesla CEO Elon Musk and Nvidia CEO Jensen Huang, according to a statement on Thursday from the Chinese Foreign Ministry. The executives — whose combined net worthapproaches $1 trillion— lead companies with major interests in China, despite years of trade disputes between the world's two largest economies.

China's pledge to welcome more foreign business comes after years of escalating trade tensions with the U.S., including the Trump administration's move last year toraise tariffson Chinese imports to as much as 125% after Mr. TrumpsaidChina "was taking us for a ride."

Yet U.S. companies continue to see China's expanding middle class and massive consumer base as critical growth markets, even as it has become harder to wring profits from financially struggling consumers in the U.S. and other developed economies.

The White House said that several American business leaders participated in a portion of a broader meeting between U.S. and Chinese officials.

"The two sides discussed ways to enhance economic cooperation between countries, including expanding market access for American businesses into China and increasing Chinese investment," a White House official said in a readout of the meeting.

The CEOs accompanying Mr. Trump include:

Cristiano Amon, CEO of QualcommTim Cook, CEO of AppleLawrence Culp Jr., CEO of GE AerospaceLarry Fink, CEO of BlackRockJane Fraser, CEO of CitigroupJensen Huang, CEO of NvidiaRyan McInerney, CEO of VisaSanjay Mehrotra, CEO of Micron TechnologyMichael Miebach, CEO of MastercardElon Musk, CEO of Tesla and SpaceXKelly Ortberg, CEO of BoeingStephen Schwarzman, CEO of BlackstoneBrian Sikes, CEO of CargillDavid Solomon, CEO of Goldman SachsJacob Thaysen, CEO of IlluminaSigns of conciliation?

Based on the CEOs attending the talks, China could take several steps to ease economic tensions with the U.S., according to analysts with Eurasia Group, a political risk consultancy.

"We continue to expect the two sides to announce increased trade and tariff adjustments in non-sensitive sectors, including Chinese purchases of U.S. agricultural products (including beef), Boeing aircraft and energy," they said in a report.

China could also ease restrictions on foreign financial services firms, lower antitrust barriers or, for Tesla, give the electric car maker the green light to roll out fully autonomous driving, according to Eurasia Group.

The trip is already paying dividends for some of the CEOs accompanying Mr. Trump, including Boeing CEO Kelly Ortberg. On Thursday, the president told Fox News host Sean Hannity that China had agreed to buy 200 Boeing 737 Max jets, up from an earlier deal for 50 aircraft.

Mr. Trump said that Xi has also agreed to buy more soybeans, a boon for U.S. farmers who have been hurt by China's retaliatory decision a year ago tohalt purchasesof the key agricultural export.

Historical precedent

There is ample historical precedent for business leaders accompanying U.S. presidents on high-stakes overseas trips or trade missions.

During President Obama's 2015 visit to India, for example, dozens of U.S. CEOs attended a summit to expand bilateral trade and investment. In 2000, President Bill Clinton brought leading U.S. executives to India, including representatives from General Motors, IBM, and Microsoft.

When Mr. Trump visited China in 2017, he was joined by the leaders of major U.S. banks, energy companies and technology firms.

Advertisement

"It's not unusual for CEOs to travel with the president, and I think it speaks to the fact that the Chinese-U.S. relationship is highly dependent on the countries' business relationship," Moody's Analytics chief economist Mark Zandi told CBS News. "We are the two largest economies on the planet, and how we interact with each other largely determines how our economies and the global economy are going to perform."

The presence of top executives alone could help "open up the lines of communication" between U.S. companies and Chinese officials and business leaders, he added.

"I don't think there is a very high bar here for success," Zandi said. "They just have to come away thinking they now have a channel to communicate quickly and they can trust each other."

Seats on the plane

It is rarer, though also not unprecedented, for executives to accompany presidents aboard Air Force One, as Tesla's Musk and Nvidia's Huang did with Mr. Trump, noted political scientist John Owen IV, an expert in foreign affairs and senior faculty fellow at The Miller Center at the University of Virginia.

"It's a very valuable seat to fly with the president to Beijing, but the potential for corruption is also present," he said.

"It seems to be consistent with how Trump has handled relationships with business leaders," Owen added, noting the high-profile CEOs who were seated prominently at Mr. Trump's 2025 inauguration.

Chips and AI

For the U.S. CEOs accompanying Mr. Trump, the broader goals include bolstering sales to Chinese consumers and businesses, as well as ensuring their companies are positioned to win key manufacturing and trade agreements.

Apple, for instance, is thelargest smartphonebrand in China, although it faces intense competition from local rivals such as Huawei and Xiaomi. The Cupertino, California-based company also relies on Chinese partners such as Foxconn, the world's largest contract electronics manufacturer, to produce the bulk of its products, which are shipped across the globe.

Semiconductor giant Nvidia is seeking broader access to China's AI market as U.S. export controls threaten sales of its advanced chips, Wedbush Securities analyst Dan Ives said in a report. Such access comes as Chinese firms are racing to develop domestic alternatives.

"What is at stake is not just one trip or one headline but the direction of AI supply chains, the shape of future export controls and the degree to which US chip leadership remains monetizable in China," Ives said.

Critical access

A number of major U.S. financial companies are also represented on the trade trip, including BlackRock CEO Larry Fink and Citigroup CEO Jane Fraser.

BlackRock is seeking broader access to China's fast-growing wealth and retirement markets while navigating increasing political scrutiny in both Washington and Beijing. Citigroup, meanwhile, wants broader access to China's financial markets, partly to help its clients engage in cross-border transactions.

"We have had huge interest and a large number of investors and companies coming to China to understand what's happening here, as well as the Chinese companies and investors that are looking much more externally now," FrasertoldBloomberg News last year.

Also among the executives in China with U.S. officials is Jacob Thaysen, the only biotech industry representative on the trip. ThaysentoldBloomberg last year that export restrictions have hurt Illumina's sales of DNA-sequencing technology in China.

"We want to be a part of China," Thaysen said, according to the news service.

Why are so many U.S. CEOs in China with Trump, and what do they want?

Tech CEOs in China with Trump make cases for more economic partnerships 02:16 Chinese President Xi Jinping told U.S. CEOstraveling...
US Supreme Court lets abortion pill mail delivery continue

By Andrew Chung

Reuters

May 14 (Reuters) - The U.S. Supreme Court on Thursday allowed the abortion pill to be prescribed through telemedicine and dispensed by mail, restoring for now a 2023 federal rule challenged by Republican-governed Louisiana that had made access to the medication easier.

The justices granted requests by two manufacturers of the ‌abortion pill, called mifepristone, to lift a lower court's block on the rule that was issued by the U.S. Food and Drug Administration during Democratic former ‌President Joe Biden's administration, while the legal challenge plays out.

Conservative Justices Samuel Alito and Clarence Thomas dissented from the decision.

The New Orleans-based 5th U.S. Circuit Court of Appeals on May 1 had ordered the imposition of a previous federal ​rule that required an in-person clinician visit in order to receive mifepristone.

Drugmakers Danco Laboratories and GenBioPro appealed the 5th Circuit action restricting access to mifepristone. The Supreme Court in interim decisions on May 4 and May 11 put the 5th Circuit's May 1 action on hold to give the justices more time to decide how to proceed.

The case has put the contentious issue of abortion back in front of the justices, with the November U.S. congressional elections looming and President Donald Trump's fellow Republicans fighting to retain control of Congress.

SUPREME COURT'S DOBBS RULING

The ongoing battles over ‌abortion rights follow the Supreme Court's 2022 ruling that overturned its ⁠1973 Roe v. Wade precedent that had recognized a woman's constitutional right to terminate her pregnancy and legalized abortion nationwide.

That ruling, in a case called Dobbs v. Jackson Women's Health Organization, prompted 13 states to enact near-total bans on the procedure, while several others sharply restrict access. ⁠Those laws have driven a surge in medication abortion.

Since the Dobbs ruling, anti-abortion advocates have targeted mifepristone, claiming that it is unsafe for women to take and that the FDA should not have approved it or relaxed limits on its use.

Abortion rights advocates have called the legal challenges to mifepristone the biggest threat to abortion access in the United States since the court's Dobbs decision.

Advertisement

The Supreme Court ​in ​2024 unanimously rejected an initial bid by anti-abortion groups and doctors to roll back FDA regulations that had ​eased access to the drug, ruling that these plaintiffs lacked the ‌necessary legal standing to pursue the challenge.

The brand-name version of mifepristone, Mifeprex, is Danco's only product, and GenBioPro derives most of its revenue from the generic version, the companies said in court filings.

The FDA has said mifepristone was approved based on scientific evidence and continues to be safe and effective for its intended purpose when used as directed.

Reproductive health experts note that hundreds of clinical trials, studies and medical reviews have shown that mifepristone is safe and that complications are exceedingly rare. They have said abortion opponents have misrepresented studies that actually show that complications and serious adverse events for women who have accessed the pill by telehealth and the mail are rare.

MIFEPRISTONE WAS APPROVED IN 2000

Mifepristone was given FDA regulatory approval in ‌2000.

Medication abortion, typically a two-drug regimen consisting of mifepristone followed by misoprostol, accounts for about two-thirds of ​U.S. abortions and is used to terminate a pregnancy within the first 10 weeks.

Louisiana sued the Food and ​Drug Administration in 2025 claiming that the 2023 rule that eliminated the in-person dispensing ​requirement was illegal and has allowed medication abortions to skyrocket despite the state's near-total ban on abortion. Louisiana claimed the FDA ignored the risks ‌of serious adverse events posed by mifepristone by women taking it, including ​sepsis and hemorrhaging.

Danco Laboratories and GenBioPro intervened ​in the litigation to defend the regulation. Republican President Donald Trump's administration opposed the state's challenge, citing an ongoing review of safety regulations concerning mifepristone. The administration also argued that Louisiana does not have legal standing to pursue its case.

In April, U.S. District Judge David Joseph in Lafayette, Louisiana, declined to block the regulation but agreed ​with the administration to put the case on hold pending the ‌review. A three-judge 5th Circuit panel subsequently blocked the regulation, deciding that Louisiana was likely to prevail in its legal challenge.

Abortion rights advocates have called ​the Trump administration's review politically motivated and unnecessary given decades of studies showing the safety of mifepristone. They have said that the review could lead to ​tighter restrictions on the medication.

(Reporting by Andrew Chung in New York; Editing by Will Dunham)

US Supreme Court lets abortion pill mail delivery continue

By Andrew Chung May 14 (Reuters) - The U.S. Supreme Court on Thursday allowed the abortion pill to be prescribed through telemedi...
Aaron Donald reveals 2 teams wanted him to change positions in NFL

Aaron Donald was absolutelydominant in college as a defensive tackle, despite being undersized for the position. TheRamsdrafted him in 2014 and kept him on the interior, but at least two teams saw him playing a different spot in the NFL.

USA TODAY

During an appearance on the “Not Just Football” podcast with Cameron Heyward, Donald revealed that the Pittsburgh Steelers asked him if he would play linebacker in the NFL. The Arizona Cardinals also saw him as a linebacker.

“There’s a chance I go to the Pittsburgh Steelers, but I was like, ‘Nah, they asked me, would I want to play linebacker?’ At the time, I’m like, ‘Yeah, I’ll play wherever y’all want me to play,’” he recalled.

Heyward’s reaction says it all.

“They wanted you to play linebacker?” Heyward asked, almost stunned.

Advertisement

“They wanted me to be a stand-up guy,” Donald said. “They wanted me to be – like, Arizona, the Steelers, had me on the board doing linebacker— just running through the stuff. They wanted me to kind of rush from a two-point stance. I never did it but hey, I work hard enough, I’ll get used to it.”

The Steelers have traditionally run a 3-4 defense, so in their scheme, they would’ve wanted Donald to play outside linebacker – a la Joey Porter, T.J. Watt and the other great edge rushers in Pittsburgh. When the Rams drafted Donald, they were running a 4-3 front, which fit him well.

But even after they shifted to a 3-4 scheme in 2017 under Wade Phillips, Donald thrived – still from his defensive tackle spot. In fact, he was as good as ever, winning Defensive Player of the Year in 2017, 2018 and 2020.

Knowing how hard he works and how talented he is, Donald would’ve made it work as a stand-up edge rusher with the Steelers, but there’s no question his best position was inside at defensive tackle.

This article originally appeared on Rams Wire:Aaron Donald says Steelers, Cardinals wanted him to play OLB in NFL

Aaron Donald reveals 2 teams wanted him to change positions in NFL

Aaron Donald was absolutelydominant in college as a defensive tackle, despite being undersized for the position. TheRamsdrafted him in ...
Americans Abroad Five: Injury bug strikes at worst possible time

With a month until the World Cup kicks off, this was not the week that U.S. men's national team fans would have hoped for.

USA TODAY

No less than four Americans Abroad went down with injuries during the past week. There is nothing severe among the group but it appears that at best, the players will enter the World Cup with a shortage of recent minutes.

But for one player at least, their World Cup dream looks like it's already over.

This week's Five will take a look at an unexpected late injury crisis for the USMNT.

Johnny Cardoso's World Cup dream likely over

We'll kick off with Johnny Cardoso – not because he is the most important player injured this week, but because he seems the most likely to miss the World Cup.

The Atlético Madrid midfieldersuffered a "high-grade" right ankle sprainduring training this week, which could spell the end of his hopes for Mauricio Pochettino's squad. Atléticoannouncedon Monday that Cardoso will undergo surgery.

Even low-grade sprains can sideline players for multiple weeks and for someone like Cardoso, who would have been on the roster bubble even if healthy, a high-grade sprain and surgery is probably too much to recover from.

Cardoso has been a hugely frustrating player from a USMNT perspective. At the club level the 24-year-old has been one of the standout holding midfielders in La Liga, but for the U.S. he's been injury-prone and inconsistent. His World Cup dream might now have to wait until 2030.

Christian Pulisic's year goes from bad to worse

Plenty has gone wrong for Christian Pulisic in the past few months, but he had at least managed to stay relatively healthy amid a huge dip in form.

But that is no longer the case afterPulisic was forced to missAC Milan's 3-2 defeat to Atalanta on Sunday with a glute muscle injury. Milan is suffering a late-season tailspin that has seen the club go from title contender to desperately trying to hold onto a top-four spot.

The early word on the injury is that it isn't severe, but any fitness issue this close to the World Cup is a concern for a player who will likely have to regain form if the U.S. wants to make a run this summer.

Pulisic's drought is becoming an increasingly big story: no USMNT goals since 2024 and none for AC Milan since 2025. Those two droughts are now more likely to be in effect when the World Cup kicks off.

Tim Weah misses Marseille match

Tim Weah has had a solid season at Marseille, starting the bulk of his side's games while toggling between a defensive and attacking role on the wing.

Advertisement

Weah was forced to miss Marseille's 1-0 win over Le Havre on Sunday with a muscle injury, which was unfortunately timed during a campaign in which the 26-year-old has mostly stayed healthy.

Thankfully,per L'Equipe, the injury isn't serious and Marseille is hopeful Weah will be fit for Marseille's season finale on Sunday, May 17.

Weah's spot in the USMNT picture has never been in doubt, though he is on the bubble when it comes to a starting role. Should he be healthy, Weah's pace and versatility will be crucial for the U.S. come this summer.

Tanner Tessmann out for the season

Like Weah, Tanner Tessmann is on the right side of the World Cup roster bubble after a strong campaign in France.

And also like Weah, Tessmann is dealing with a muscle injury at the worst possible time.

The Lyon midfielder's injury appears to be worse than Weah's, as he's already beenruled out for the rest of the regular season.Multiple reports have indicated, however, that Tessmann should be fit in time for the World Cup.

Still, for a player who isn't guaranteed a consistent role at the tournament, suffering any kind of injury now is far from ideal.

Lyon's US midfielder #06 Tanner Tessmann reacts during the French L1 football match between RC Strasbourg Alsace and Olympique Lyonnais (OL) at the Stade de la Meinau in Strasbourg on February 22, 2026.

Gio Reyna is on the board

We couldn't let the Five conclude without at leastsomegood news, which we found this weekend in Germany.

Gio Reyna would not have hoped that his first goal for Borussia Mönchengladbach wouldn't come until May, but the USMNT midfielder avoided being completely shut out this season by scoring a late consolation in Saturday's 3-1 loss to Augsburg.

It's been yet another frustrating season for the 23-year-old, who has once again failed to stay fit and earn a consistent role with his club.

But Reyna has at least been trending slightly upward of late, earning four consecutive appearances off the bench after failing to see the pitch in five of six league matches.

Reyna's 32-minute outing on Saturday was his longest of 2026. It's modest progress but for a player right on the World Cup roster bubble, any kind of forward momentum could make the difference.

This article originally appeared on USA TODAY:Americans Abroad: USMNT players hit by injury bug

Americans Abroad Five: Injury bug strikes at worst possible time

With a month until the World Cup kicks off, this was not the week that U.S. men's national team fans would have hoped for. No ...

 

INS MAG © 2015 | Distributed By My Blogger Themes | Designed By Templateism.com